Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PepGen Inc. - Common Stock
(NQ:
PEPG
)
1.760
-0.020 (-1.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PepGen Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 11, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
PEPG Stock Earnings: PepGen Misses EPS for Q2 2024
↗
August 08, 2024
PEPG stock results show that PepGen missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
PepGen Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
August 08, 2024
From
PepGen Inc.
Via
Business Wire
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 02, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
PEPG Stock Earnings: PepGen Beats EPS for Q1 2024
↗
May 14, 2024
PEPG stock results show that PepGen beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
PEPG Stock Earnings: PepGen Beats EPS for Q4 2023
↗
March 06, 2024
PEPG stock results show that PepGen beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
↗
July 31, 2024
Via
Benzinga
Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
↗
July 31, 2024
Via
Benzinga
Topics
Stocks
PEPG Investors Have Opportunity to Join PepGen Inc. Securities Fraud Investigation with the Schall Law Firm
July 31, 2024
From
The Schall Law Firm
Via
Business Wire
PepGen Announces Positive Data from Low-Dose Cohort of PGN-EDO51 in Ongoing CONNECT1-EDO51 Phase 2 Clinical Trial for Treatment of Duchenne Muscular Dystrophy
July 30, 2024
From
PepGen Inc.
Via
Business Wire
PepGen Appoints Afsaneh Mohebbi, Ph.D., as SVP, Portfolio and Program Management and Dave Borah, CFA, as SVP, Investor Relations and Corporate Communications
July 02, 2024
From
PepGen Inc.
Via
Business Wire
PepGen Announces Executive Team Promotions
June 11, 2024
From
PepGen Inc.
Via
Business Wire
PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 14, 2024
From
PepGen Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 12, 2024
Via
Benzinga
Insiders Buying GameStop And 2 Other Stocks
↗
April 10, 2024
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
Via
Benzinga
PepGen to Participate in Upcoming Investor Conferences
March 13, 2024
From
PepGen Inc.
Via
GlobeNewswire
PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
March 13, 2024
From
PepGen Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 07, 2024
Via
Benzinga
PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
March 06, 2024
From
PepGen Inc.
Via
GlobeNewswire
PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
March 04, 2024
From
PepGen Inc.
Via
GlobeNewswire
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1
February 20, 2024
From
PepGen Inc.
Via
GlobeNewswire
Over $37M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
↗
February 14, 2024
Although U.S. stocks closed sharply lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 07, 2024
Via
Benzinga
PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock
February 07, 2024
From
PepGen Inc.
Via
GlobeNewswire
PepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 data
February 06, 2024
PepGen stock is moving higher on expectations of positive Phase 2 clinical trial results for its Duchenne muscular dystrophy (DMD) gene therapy
Via
MarketBeat
Top 4 Health Care Stocks That May Crash This Quarter
↗
February 02, 2024
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
January 30, 2024
Via
Benzinga
Mary Beth DeLena Joins PepGen as General Counsel and Secretary
January 17, 2024
From
PepGen Inc.
Via
GlobeNewswire
PepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51 for Duchenne Muscular Dystrophy Patients Amenable to Exon 51 Skipping
January 08, 2024
From
PepGen Inc.
Via
GlobeNewswire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
